Safe Bulkers
SB
8.76
+0.31
+3.61%
Safe Bulkers
US · SB
#3276 by market cap
8.76
+0.31
+3.61%
Live - 5344 symbols - heartbeat 129s ago
· 2026-10-08 10:11
Pre-market
8.55
+1.18%
After-hours
8.74
+3.43%
- Market cap
- 996.61M
- P/E (TTM)i
- 11.37
- P/Bi
- 1.15
- EPSi
- 0.30
- Div yieldi
- 2.40%
- 52W posi
- 90%
Reader sentiment
Are you bullish or bearish on SB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.02, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -10.37% YoY
Margins
- Gross margin
- 35.93%
- Operating margin
- 23.71%
- Net margin
- 11.08%
Key ratios & quality
- Enterprise valuei
- 1.38B
- Altman Z-Scorei
- 2.02
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 193.19M | 197.76M | 198.16M | 329.03M | 349.72M | 284.40M | 307.63M | 275.74M |
| Gross profit | 75.23M | 65.17M | 32.22M | 194.87M | 210.02M | 119.41M | 140.17M | 99.06M |
| Selling & admin expenses | 19.24M | 20.64M | 21.50M | 22.50M | 21.80M | 23.76M | 27.04M | 29.85M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 55.99M | 44.11M | 10.48M | 172.37M | 184.65M | 93.77M | 111.87M | 65.37M |
| Pretax profit | 27.68M | 16.04M | -12.91M | 174.35M | 172.55M | 77.35M | 97.38M | 38.56M |
| Tax | -- | -- | -- | -- | -- | -- | -- | -- |
| Net profit | 27.68M | 16.04M | -12.91M | 174.35M | 172.55M | 77.35M | 97.38M | 38.56M |
| Basic EPS | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Diluted EPS | 0.16 | 0.04 | -0.25 | 1.44 | 1.36 | 0.61 | 0.83 | 0.30 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 64.35M | 65.75M | 73.08M | 72.57M | 74.39M | 87.47M |
| Gross profit | 21.57M | 18.19M | 28.79M | 30.51M | 33.69M | 43.04M |
| Selling & admin expenses | 6.66M | 7.70M | 7.54M | 7.96M | 7.22M | 7.13M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 14.92M | 10.49M | 21.25M | 18.71M | 26.47M | 35.91M |
| Pretax profit | 7.25M | 1.70M | 17.78M | 11.84M | 22.21M | 35.16M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | 7.25M | 1.70M | 17.78M | 11.84M | 22.21M | 35.16M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.05 | 0.00 | 0.15 | 0.10 | 0.20 | 0.33 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 101.26M | 135.99M | 134.73M | 124.12M | 157.70M | 146.72M | 165.39M | 200.60M |
| Cash & ST investments | 81.77M | 106.38M | 101.82M | 102.08M | 113.38M | 87.92M | 125.42M | 157.96M |
| Inventory | 4.14M | 9.27M | 12.04M | 8.65M | 17.32M | 16.65M | 14.88M | 19.01M |
| Total assets | 1.08B | 1.11B | 1.11B | 1.09B | 1.25B | 1.34B | 1.40B | 1.40B |
| Total current liabilities | 54.61M | 86.78M | 104.72M | 88.69M | 91.32M | 55.73M | 86.47M | 69.06M |
| Short-term debt | 36.19M | 64.05M | 75.78M | 61.86M | 43.56M | 24.78M | 58.19M | 42.37M |
| Long-term debt | 538.51M | 537.00M | 531.88M | 315.80M | 370.81M | 482.39M | 478.45M | 497.77M |
| Total liabilities | 593,367,000.00 | 624,701,000.00 | 642,770,000.00 | 415,080,000.00 | 474,002,000.00 | 547,305,000.00 | 571,478,000.00 | 572,475,000.00 |
| Total equity | 482.83M | 489.94M | 462.86M | 679.24M | 771.92M | 792.51M | 831.62M | 830.71M |
| Retained earnings | 111.28M | 115.62M | 90.31M | 253.86M | 392.79M | 439.46M | 507.34M | 517.29M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 152.38M | 161.34M | 158.95M | 200.60M | 249.41M | 211.35M |
| Cash & ST investments | 120.21M | 117.43M | 115.25M | 157.96M | 171.78M | 134.54M |
| Inventory | -- | -- | -- | 19.01M | -- | -- |
| Total assets | 1.38B | 1.41B | 1.37B | 1.40B | 1.42B | 1.43B |
| Total current liabilities | 87.50M | 94.84M | 58.53M | 69.06M | 181.41M | 210.86M |
| Short-term debt | 59.51M | 61.95M | 34.50M | 42.37M | 155.06M | 171.56M |
| Long-term debt | 460.21M | 490.64M | 481.78M | 497.77M | 388.94M | 339.88M |
| Total liabilities | 554,526,000.00 | 593,675,000.00 | 546,331,000.00 | 572,475,000.00 | 577,213,000.00 | 558,885,000.00 |
| Total equity | 826.81M | 815.58M | 826.28M | 830.71M | 843.19M | 870.28M |
| Retained earnings | -- | -- | -- | 517.29M | -- | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 85.45M | 58.28M | 63.38M | 217.21M | 218.05M | 122.21M | 130.46M | 102.29M |
| Depreciation & amortization | 48.07M | 50.31M | 54.27M | 52.36M | 49.52M | 54.13M | 58.14M | 59.88M |
| Free cash flow | 39.52M | 19.04M | 12.93M | 107.98M | 34.77M | -86.90M | -14.32M | 60.30M |
| Dividends paid | -11.39M | -11.50M | -11.50M | -11.20M | -33.63M | -30.68M | -29.50M | -28.61M |
| Stock buybacks / issuance | -617.00K | -4.15M | -6.01M | 71.54M | -9.05M | -26.22M | -28.92M | -11.01M |
| Ending cash balance | 62.59M | 92.64M | 112.19M | 111.25M | 59.09M | 59.06M | 91.56M | 151.25M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 29.90M | 19.13M | 20.08M | 33.19M | 35.20M | 42.68M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 29.90M | -12.21M | 51.41M | -8.80M | 35.20M | -16.53M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.54 | 0.93 | -5.52 | 29.11 | 22.55 | 8.87 | 11.01 | 3.68 |
| ROA %i | 1.54 | 0.40 | -2.28 | 14.87 | 13.98 | 5.36 | 6.52 | 2.18 |
| ROIC %i | 3.19 | 2.01 | -0.44 | 16.44 | 15.68 | 6.92 | 8.27 | 3.61 |
| 5-year avg ROE %i | -7.13 | -7.11 | -6.35 | 1.78 | 10.12 | 11.18 | 13.20 | 15.04 |
| EBIT margin %i | 27.64 | 21.67 | 4.20 | 57.46 | 54.24 | 35.89 | 41.85 | 24.99 |
| FCF / sales %i | 20.45 | 9.63 | 6.53 | 32.82 | 9.94 | -- | -- | 21.87 |
| Current ratioi | 1.85 | 1.57 | 1.29 | 1.40 | 1.73 | 2.63 | 1.91 | 2.90 |
| Quick ratioi | 1.72 | 1.41 | 1.02 | 1.25 | 1.32 | 1.74 | 1.62 | 2.46 |
| Debt / assetsi | 53.40 | 53.92 | 54.96 | 34.51 | 33.26 | 37.85 | 38.25 | 38.49 |
| LT debt / equityi | 115.61 | 113.60 | 119.61 | 46.50 | 48.04 | 60.87 | 57.54 | 59.92 |
| Interest coveragei | 2.08 | 1.60 | 0.39 | 12.85 | 11.07 | 4.13 | 4.10 | 2.27 |
| Revenue CAGR (3Y) %i | 14.91 | 21.68 | 10.21 | 19.42 | 20.93 | 12.80 | -2.22 | -7.62 |
| Net income CAGR (3Y) %i | -- | -- | -- | 84.67 | 120.76 | -- | -17.65 | -39.31 |
| FCF CAGR (3Y) %i | -- | -- | -- | 39.80 | 22.22 | -- | -- | 20.14 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.83 | 5.60 | 4.61 | 3.68 | 5.45 | 9.37 |
| ROA %i | 5.22 | 3.31 | 2.80 | 2.18 | 3.25 | 5.57 |
| ROIC %i | 6.87 | 4.91 | 4.34 | 3.61 | 4.39 | 6.70 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 37.83 | 30.34 | 27.95 | 24.99 | 29.04 | 37.30 |
| FCF / sales %i | -- | -- | -- | 21.87 | 22.95 | 19.93 |
| Current ratioi | 1.74 | 1.70 | 2.72 | 2.90 | 1.37 | 1.00 |
| Quick ratioi | 1.37 | 1.24 | 1.97 | 2.46 | 0.95 | 0.64 |
| Debt / assetsi | 37.62 | 39.21 | 37.61 | 38.49 | 38.30 | 35.79 |
| LT debt / equityi | 55.66 | 60.16 | 58.31 | 59.92 | 46.13 | 39.05 |
| Interest coveragei | 3.60 | 2.74 | 2.50 | 2.27 | 2.82 | 4.14 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 10:11:03 · For reference only, not investment advice and not tailored to your situation.